Menu

Close

Stories & News

Resources

Stay Informed

Stay Informed

Stories

Pfizer’s Long Streak of Returning Capital to Investors

Pfizer has a long track record of quarterly dividends. In 2023, Pfizer has continued to return capital to shareholders with a dividend that has increased for the 14th consecutive year and a yield above the S&P 500 average.

*Data from Nasdaq Data Link, S&P 500 Dividend Yield by Month, tracking the 12-month dividend per share of 500 of the leading publicly traded companies divided by their stock price, as of June 30, 2023. Accessible here.

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
 


Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.